Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia

Tamar Tadmor, Ohad Benjamini, Andrei Braester, Galia Rahav, Lior Rokach

Research output: Contribution to journalLetterpeer-review

19 Scopus citations
Original languageEnglish
Pages (from-to)2727-2730
Number of pages4
JournalLeukemia
Volume35
Issue number9
DOIs
StatePublished - Sep 2021
Externally publishedYes

Funding

FundersFunder number
Janssen PharmaceuticalsEV00261620

    Cite this